Compare Wockhardt with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT vs ALKEM LABORATORIES - Comparison Results

WOCKHARDT     Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT ALKEM LABORATORIES WOCKHARDT/
ALKEM LABORATORIES
 
P/E (TTM) x -22.4 - - View Chart
P/BV x 1.2 6.3 18.7% View Chart
Dividend Yield % 0.0 0.7 0.5%  

Financials

 WOCKHARDT   ALKEM LABORATORIES
EQUITY SHARE DATA
    WOCKHARDT
Mar-18
ALKEM LABORATORIES
Mar-16
WOCKHARDT/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs1,0121,589 63.7%   
Low Rs5321,232 43.1%   
Sales per share (Unadj.) Rs355.9417.5 85.2%  
Earnings per share (Unadj.) Rs-60.356.3 -107.1%  
Cash flow per share (Unadj.) Rs-46.864.7 -72.3%  
Dividends per share (Unadj.) Rs0.0112.70 0.1%  
Dividend yield (eoy) %00.9 0.1%  
Book value per share (Unadj.) Rs257.8292.9 88.0%  
Shares outstanding (eoy) m110.63119.57 92.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.23.4 64.2%   
Avg P/E ratio x-12.825.1 -51.1%  
P/CF ratio (eoy) x-16.521.8 -75.7%  
Price / Book Value ratio x3.04.8 62.2%  
Dividend payout %022.6 -0.1%   
Avg Mkt Cap Rs m85,379168,653 50.6%   
No. of employees `0006.3NA-   
Total wages/salary Rs m9,3719,171 102.2%   
Avg. sales/employee Rs Th6,295.0NM-  
Avg. wages/employee Rs Th1,498.3NM-  
Avg. net profit/employee Rs Th-1,066.3NM-  
INCOME DATA
Net Sales Rs m39,36949,915 78.9%  
Other income Rs m1,2021,645 73.1%   
Total revenues Rs m40,57151,561 78.7%   
Gross profit Rs m188,482 0.2%  
Depreciation Rs m1,4951,006 148.7%   
Interest Rs m2,555671 381.0%   
Profit before tax Rs m-2,8308,451 -33.5%   
Minority Interest Rs m0-114 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-3,5820-   
Tax Rs m2571,606 16.0%   
Profit after tax Rs m-6,6696,731 -99.1%  
Gross profit margin %017.0 0.3%  
Effective tax rate %-9.119.0 -47.8%   
Net profit margin %-16.913.5 -125.6%  
BALANCE SHEET DATA
Current assets Rs m33,79627,062 124.9%   
Current liabilities Rs m26,91715,324 175.7%   
Net working cap to sales %17.523.5 74.3%  
Current ratio x1.31.8 71.1%  
Inventory Days Days7967 119.3%  
Debtors Days Days8941 216.2%  
Net fixed assets Rs m39,66412,610 314.6%   
Share capital Rs m553239 231.4%   
"Free" reserves Rs m27,96834,490 81.1%   
Net worth Rs m28,52235,027 81.4%   
Long term debt Rs m21,7311,212 1,793.6%   
Total assets Rs m81,62054,387 150.1%  
Interest coverage x-0.113.6 -0.8%   
Debt to equity ratio x0.80 2,202.7%  
Sales to assets ratio x0.50.9 52.6%   
Return on assets %-5.013.6 -37.0%  
Return on equity %-23.419.2 -121.7%  
Return on capital %-7.724.9 -30.9%  
Exports to sales %012.9 0.0%   
Imports to sales %03.1 0.0%   
Exports (fob) Rs mNA6,461 0.0%   
Imports (cif) Rs mNA1,540 0.0%   
Fx inflow Rs m9,8076,563 149.4%   
Fx outflow Rs m1,7893,012 59.4%   
Net fx Rs m8,0193,552 225.8%   
CASH FLOW
From Operations Rs m6847,259 9.4%  
From Investments Rs m6,3021,864 338.1%  
From Financial Activity Rs m-7,695-9,273 83.0%  
Net Cashflow Rs m-664-150 442.7%  

Share Holding

Indian Promoters % 74.5 66.9 111.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.3 33.1 6.9%  
FIIs % 7.7 0.0 -  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 0.0 -  
Shareholders   67,757 68,381 99.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT With:   NATCO PHARMA  FRESENIUS KABI ONCO.  FDC LTD.  TORRENT PHARMA  STRIDES PHARMA SCIENCE  

Compare WOCKHARDT With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Slumps 470 Points; Energy and Banking Stocks Witness Selling(Closing)

Indian share markets witnessed negative trading activity throughout the day and ended deep in the red. The BSE Sensex fell over 550 points intraday and breached the 36,000 mark.

Related Views on News

WOCKHARDT Announces Quarterly Results (1QFY20); Net Profit Up 57.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, WOCKHARDT has posted a net profit of Rs 369 m (up 57.2% YoY). Sales on the other hand came in at Rs 9 bn (down 14.3% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

WOCKHARDT Announces Quarterly Results (4QFY19); Net Profit Up 90.8% (Quarterly Result Update)

May 7, 2019 | Updated on May 7, 2019

For the quarter ended March 2019, WOCKHARDT has posted a net profit of Rs 139 m (up 90.8% YoY). Sales on the other hand came in at Rs 10 bn (down 3.8% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

WOCKHARDT LTD. Announces Quarterly Results (3QFY19); Net Profit Down 80.6% (Quarterly Result Update)

Jan 29, 2019 | Updated on Jan 29, 2019

For the quarter ended December 2018, WOCKHARDT LTD. has posted a net profit of Rs 769 m (down 80.6% YoY). Sales on the other hand came in at Rs 10 bn (up 4.0% YoY). Read on for a complete analysis of WOCKHARDT LTD.'s quarterly results.

WOCKHARDT LTD. Announces Quarterly Results (2QFY19); Net Profit Down 158.2% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, WOCKHARDT LTD. has posted a net profit of Rs 228 m (down 158.2% YoY). Sales on the other hand came in at Rs 11 bn (up 10.1% YoY). Read on for a complete analysis of WOCKHARDT LTD.'s quarterly results.

WOCKHARDT LTD. Announces Quarterly Results (1QFY19); Net Profit Down 81.4% (Quarterly Result Update)

Aug 6, 2018 | Updated on Aug 6, 2018

For the quarter ended June 2018, WOCKHARDT LTD. has posted a net profit of Rs 862 m (down 81.4% YoY). Sales on the other hand came in at Rs 10 bn (up 13.1% YoY). Read on for a complete analysis of WOCKHARDT LTD.'s quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT SHARE PRICE


Sep 19, 2019 03:35 PM

TRACK WOCKHARDT

  • Track your investment in WOCKHARDT with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE WOCKHARDT WITH

MARKET STATS